Michael Hearne
Equibles does not estimate personal net worth.
Get an email with a short summary when Aurinia Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.
Get AUPH alertsAbout Michael Hearne
Michael Hearne is recorded as CFO at Aurinia Pharmaceuticals Inc. (AUPH). The newest filing on record that lists Michael Hearne as CFO at Aurinia Pharmaceuticals Inc. (AUPH) is dated April 21, 2026. Aurinia Pharmaceuticals Inc. reported in an 8-K filed March 23, 2026 that Michael Hearne was appointed Chief Financial Officer, effective March 23, 2026. Aurinia Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Aurinia Pharmaceuticals Inc. includes Jeffrey Bailey (CEO and Board Member), Kevin Tang (CEO and Board Member), Peter Greenleaf (CEO and Board Member) and 7 others.
“Effective March 23, 2026, Aurinia’s Board of Directors appointed Michael Hearne as Aurinia’s Chief Financial Officer and as Aurinia’s principal financial officer and principal accounting officer.”
Affiliation history
-
Current
Start not stated–present
Last confirmed April 21, 2026
Company network
Leadership on record at Aurinia Pharmaceuticals Inc.
- Jeffrey Bailey CEO, Board Member
- Kevin Tang CEO, Board Member
- Peter Greenleaf CEO, Board Member
- Joseph Miller CFO
- Matthew Donley COO
- Ryan Cole COO
- Stephen Robertson General Counsel
- Craig Johnson Board Member
- Dr. Karen Smith Board Member
- Dr. Robert T. Foster Board Member